Lifeward appoints Ronen Tsimerman as CFO with NIS 70,000 monthly salary
קריאה של פחות מדקה
Lifeward appointed Ronen Tsimerman as chief financial officer, effective November 1, 2026, and will enter into an employment agreement with him.
| Individual | Ronen Tsimerman |
| Role | Chief financial officer, principal financial officer and principal accounting officer |
| Type of Change | Appointed; employment agreement to be entered into |
| Effective Date | November 1, 2026 |
| Reason | Not disclosed |
| Background Details | Most recently CFO of Scopio Labs; previously CFO of IceCure Medical, Insuline Medical and Mer-Group divisions, and COO of IceCure Medical. |
| Compensation/Agreement Terms | Subject to shareholder approval of the renewed compensation policy: NIS 70,000 gross monthly base salary, annual performance bonus targeted at no less than four monthly salaries, and a transaction bonus. Three-month termination notice, increasing to four months after a CEO change. |
Original SEC Filing: Lifeward Ltd. [ LFWD ] - 8-K - Oct. 27, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.